Francesco Pietro Crispino
Director/Board Member at APOLLO TYRES LIMITED
Profile
Francesco Pietro Crispino is the founder of Greater Pacific Capital LLP.
He is currently an Independent Director at Apollo Tyres Ltd.
He was previously a Director at Stallergenes Greer Ltd.
from 2019 to 2021 and held the position of Chief Strategy Officer & Executive VP at BCE, Inc. Mr. Crispino has a graduate degree from the University of Oxford and the University of Chicago, and an undergraduate degree from the University of Toronto.
Francesco Pietro Crispino active positions
| Companies | Position | Start |
|---|---|---|
| APOLLO TYRES LIMITED | Director/Board Member | 02/07/2020 |
Former positions of Francesco Pietro Crispino
| Companies | Position | End |
|---|---|---|
| STALLERGENES GREER | Director/Board Member | 30/12/2021 |
Greater Pacific Capital LLP
 Greater Pacific Capital LLP Investment ManagersFinance Greater Pacific Capital LLP (Greater Pacific Capital) is a private equity firm founded in 2005 by Ketan J Patel and Methusalah Joseph Sealy. The firm is headquartered in London. | Founder | - |
| BCE INC. | Corporate Officer/Principal | - |
Training of Francesco Pietro Crispino
| University of Oxford | Graduate Degree |
| The University of Chicago | Graduate Degree |
| University of Toronto | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BCE INC. | Communications |
| APOLLO TYRES LIMITED | Consumer Durables |
| Private companies | 2 |
|---|---|
Greater Pacific Capital LLP
Greater Pacific Capital LLP Investment ManagersFinance Greater Pacific Capital LLP (Greater Pacific Capital) is a private equity firm founded in 2005 by Ketan J Patel and Methusalah Joseph Sealy. The firm is headquartered in London. | Finance |
Stallergenes Greer Ltd.
 Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Francesco Pietro Crispino
